Adding mass detection to your pharmaceutical workflows—such as reaction monitoring, method development, and quality control—can improve your analytical confidence and data reliability.
What’s more, the Agilent InfinityLab LC/MSD iQ eliminates the hurdles typically
associated with moving from UV to MS detection. This smart, integrated system
enables even first-time users to achieve reliable LC/MS results. Use it to:
Labs have traditionally relied on an LC/UV approach for decades. Regulations have brought a paradigm shift with a focus on low-level impurities. Mass detection enables you to confidently identify and quantitate these trace-level impurities that are typically not detected by UV.
Want to learn more? Download our application notes:
To see the results of our complete pharma lab leadership survey, complete this form.